RA Capital Healthcare Fund LP's Sale of Vor Biopharma Inc. Common Stock

RA Capital Healthcare Fund LP, a significant shareholder and director of Vor Biopharma Inc., has filed a Form 144 indicating its intention to sell 218,043 shares of common stock. The shares were acquired through private financing transactions between February 2019 and February 2021. The aggregate market value of the shares to be sold is approximately $6,323,247. Additionally, RA Capital Healthcare Fund LP has recently sold 169,820 shares in two transactions on October 15 and 16, 2025, generating gross proceeds of $5,048,217.52. The sales are being facilitated by BTIG, LLC.